Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tracey S Otto, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Jacoby TV, Shah N, Asdourian MS, Thompson LL, Otto TS, LeBoeuf NR, Semenov Y, Christopher Dee E, Reynolds KL, Chen ST. Dermatology evaluation for cutaneous immune related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition. J Am Acad Dermatol. 2022 Sep 13. PMID: 36113616.
    Citations:    Fields:    
  2. Asdourian MS, Shah N, Jacoby TV, Semenov YR, Otto T, Thompson LL, Dee EC, Reynolds KL, Chen ST. Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade. J Am Acad Dermatol. 2022 Jun 20. PMID: 35738514.
    Citations:    Fields:    
  3. Asdourian MS, Jacoby TV, Shah N, Thompson LL, Otto T, Semenov YR, LeBoeuf NR, Reynolds KL, Dewan AK, Chen ST. Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study. J Am Acad Dermatol. 2022 Jun 17. PMID: 35724890.
    Citations:    Fields:    
  4. Jacoby TV, Otto TS, Asdourian MS, Shah N, Farcasanu M, Chang MS, Thompson LL, Reynolds KL, Chen ST. Association of pre-existing drug allergies with cutaneous immune-related adverse events among patients on immune checkpoint inhibitor therapy. Br J Dermatol. 2022 09; 187(3):424-426. PMID: 35290662.
    Citations:    Fields:    
  5. Asdourian MS, Shah N, Jacoby TV, Thompson LL, Otto T, Semenov YR, Reynolds KL, Chen ST. Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy. J Am Acad Dermatol. 2022 May 13. PMID: 35577231.
    Citations:    Fields:    
  6. Otto T, Argobi Y, Smith G, Fedeles F. A Retrospective Study of Idiopathic Granulomatous Mastitis Treatment and Outcomes. J Drugs Dermatol. 2022 Apr 01; 21(4):438-440. PMID: 35389582.
    Citations:    Fields:    Translation:Humans
  7. Chang MS, Jacoby TV, Otto TS, Shah N, Asdourian MS, Thompson LL, Reynolds KL, Chen ST. Evaluating the treatment of cutaneous adverse events and adherence to National Comprehensive Cancer Network guidelines in patients receiving immune checkpoint inhibitors. Eur J Cancer. 2022 05; 166:21-23. PMID: 35259628.
    Citations:    Fields:    Translation:Humans
  8. Asdourian MS, Otto TS, Jacoby TV, Shah N, Thompson LL, Blum SM, Reynolds KL, Semenov YR, Lawrence DP, Sullivan RJ, Boland GM, Villani AC, Chen ST. Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma. J Am Acad Dermatol. 2022 Nov; 87(5):1147-1149. PMID: 35192899.
    Citations:    Fields:    
  9. Sayegh ET, Otto TS, Garvey KD, Martin A, Lowenstein NA, Matzkin EG. Defining the Opioid Requirement in Anterior Cruciate Ligament Reconstruction. J Am Acad Orthop Surg Glob Res Rev. 2022 01 13; 6(1). PMID: 35025832; PMCID: PMC8759619.
    Citations:    Fields:    Translation:Humans
  10. Shi CR, Otto TS, Thompson LL, Chang MS, Reynolds KL, Chen ST. Methotrexate in the treatment of immune checkpoint blocker-induced bullous pemphigoid. Eur J Cancer. 2021 12; 159:34-37. PMID: 34731747.
    Citations:    Fields:    Translation:Humans
  11. Otto TS, Argobi Y, Lerwill MJ, Smith GP, Fedeles F. A retrospective study of idiopathic granulomatous mastitis diagnosis and clinical presentation. J Am Acad Dermatol. 2022 02; 86(2):467-469. PMID: 34610382.
    Citations:    Fields:    Translation:Humans
  12. Halle BR, Betof Warner A, Zaman FY, Haydon A, Bhave P, Dewan AK, Ye F, Irlmeier R, Mehta P, Kurtansky NR, Lacouture ME, Hassel JC, Choi JS, Sosman JA, Chandra S, Otto TS, Sullivan R, Mooradian MJ, Chen ST, Dimitriou F, Long G, Carlino M, Menzies A, Johnson DB, Rotemberg VM. Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy. J Immunother Cancer. 2021 10; 9(10). PMID: 34635495; PMCID: PMC8506877.
    Citations: 3     Fields:    Translation:Humans
  13. Molina GE, Otto TS, Yu Z, Foreman RK, Reynolds KL, Chen ST. Response to: "Immune checkpoint inhibitor-related Stevens-Johnson syndrome/toxic epidermal necrolysis-like reactions". J Am Acad Dermatol. 2021 08; 85(2):e111-e112. PMID: 33878410.
    Citations:    Fields:    Translation:Humans
  14. Otto TS, Bowers S, Chen ST. Dermatology's dearth of diversity: Considerations in providing support to students underrepresented in medicine at home and away. Int J Womens Dermatol. 2021 Sep; 7(4):514-515. PMID: 34621974.
    Citations:    
  15. Otto TS, Chang MS, Thompson LL, Chen ST. Limitations of morphology-based management for immune checkpoint inhibitor-related cutaneous adverse events. J Am Acad Dermatol. 2021 06; 84(6):e281-e282. PMID: 33493573.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Otto's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (30)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.